工银医疗保健股票连续3个交易日下跌，区间累计跌幅1.2%

Core Viewpoint - ICBC Medical Care Stock (000831) has experienced a decline of 0.12% on April 17, with a latest net value of 2.47 yuan, marking a cumulative drop of 1.2% over three consecutive trading days [1] Group 1: Fund Performance - The fund was established in November 2014, with a total scale of 2.644 billion yuan and a cumulative return of 146.70% since inception [1] - As of the end of 2024, institutional investors hold 0.41 million shares, accounting for 3.55% of total shares, while individual investors hold 11.19 million shares, making up 96.45% of total shares [1] Group 2: Fund Management - Current fund manager Zhao Bei has a master's degree and has been with ICBC Credit Suisse since 2010, serving as the fund manager since November 18, 2014 [2] - The current fund manager Ding Yang holds a doctoral degree and joined ICBC Credit Suisse in December 2017, taking over as fund manager on May 5, 2023 [2] Group 3: Portfolio Holdings - As of December 31, 2024, the top ten holdings of ICBC Medical Care Stock account for a total of 36.38%, with major positions including: - Heng Rui Medicine (9.51%) - WuXi AppTec (5.65%) - Mindray Medical (3.83%) - Yuyue Medical (2.88%) - Betta Pharmaceuticals (2.66%) - BeiGene (2.62%) - Aier Eye Hospital (2.41%) - Baiyang Pharmaceutical (2.33%) - Kelun Pharmaceutical (2.30%) - New Horizon Health (2.19%) [3]